Factor VII Deficiency via the F7 Gene
Use
This test is for individuals with relevant features who have a clinical or suspected diagnosis of Factor VII deficiency. It aims to detect pathogenic variants in the F7 gene that could be responsible for the condition. Testing is also applicable to reproductive partners of individuals with a known familial pathogenic variant in the F7 gene.
Special Instructions
Not provided.
Limitations
The test is developed and validated by PreventionGenetics LLC under CAP and CLIA regulations. However, it has not been cleared or approved by the US Food and Drug Administration (FDA). Results may be impacted if clinical and variant interpretations are based on incomplete clinical information.
New York Approved
Methodology
NGS
Biomarkers
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided